Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.2780
-0.0433 (-13.48%)
At close: Dec 24, 2025, 4:00 PM EST
0.2819
+0.0039 (1.40%)
After-hours: Dec 24, 2025, 4:55 PM EST
RVPH Market Cap
RVPH has a market cap or net worth of $31.99 million as of December 24, 2025. Its market cap has decreased by -42.03% in one year.
Market Cap
31.99M
Enterprise Value
23.79M
1-Year Change
-42.03%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $31.99M, an increase of 26.88%. That is a compound annual growth rate of 3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 36.97M | -56.15% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |